Greater London Authority

Queen Mary University of London, established in 1882, is a prominent U.K.-based institution offering a wide range of undergraduate, graduate, and postgraduate programs across various disciplines, including business, engineering, medicine, physics, biochemistry, mathematics, literature, economics, and language. The university is organized into three faculties: science and engineering, humanities and social sciences, and the school of medicine and dentistry. It is dedicated to impactful research that contributes to society and advances specialist knowledge. Additionally, Queen Mary manages an endowment fund that supports scholarships, academic positions, and research initiatives, enhancing its educational and public service commitments.

Macusoft is an accurate clinical decision making for the best patient outcomes, improved continually by learning.

Mursla is Cambridge-based startup developing a novel tech platform to trace tumours early in the blood via the discovery and quantification of cancer-specific exosome subpopulations.

MultiplAI Health specializes in remote preventative screening and post-treatment monitoring for complex diseases, particularly cancer. The company utilizes a liquid biopsy based on RNA sequencing and artificial intelligence to create a universal screening test that can detect various cancers from a simple blood sample. This innovative approach allows for continuous testing, making it suitable for both early detection and monitoring after treatment. By employing advanced bioinformatics and AI algorithms, MultiplAI Health's tests can analyze a vast number of biomarkers at the molecular level, facilitating large-scale screening and enabling clinicians to provide more precise prognoses and treatment plans. The remote nature of the tests not only enhances accessibility but also significantly reduces costs compared to traditional diagnostic methods.

BioMavericks developing biomarkers for detection of early-stage pancreatic cancer

King's College London (informally King's or KCL) is a public research university located in London, United Kingdom, and a constituent college of the federal University of London. King's is arguably the third-oldest university in England, having been founded by King George IV and the Duke of Wellington in 1829, receiving its royal charter in the same year. St Thomas' Hospital, which is now a teaching hospital of King's College London School of Medicine, has roots dating back to 1173. In 1836, King's became one of the two founding colleges of the University of London. King's is based in the centre of London and organised into nine academic schools, spread across four Thames-side campuses in central London and another in Denmark Hill in south London. It is one of the largest centres for graduate and post-graduate medical teaching and biomedical research in Europe; it is home to six Medical Research Council centres for <a href="https://www.dissertationcorp.co.uk/">dissertation help</a> , the most of any British university, and is a founding member of the King's Health Partners academic health sciences centre. King's has around 25,000 students and 6,113 staff and had a total income of £587 million in 2012/13, of which £164 million was from research grants and contracts. King's is a world-leading university, currently ranked 19th in the world (6th in the UK and 8th in Europe) in the 2013 QS World University Rankings, and 38th in the world (6th in the UK and 9th in Europe) in the 2013 Times Higher Education World University Rankings. There are currently 12 Nobel Prize laureates amongst King's alumni and current and former faculty. King's is a member of the Association of Commonwealth Universities, the European University Association, the Russell Group and Universities UK. It forms part of the 'golden triangle' of British universities.

iLoF, or Intelligent Lab on Fiber, is a company based in Porto, Portugal, founded in 2019. It specializes in developing a cloud-based drug discovery platform aimed at treating Alzheimer's disease. The company's innovative approach utilizes a patented photonics and artificial intelligence system to identify unique characteristics of gold-standard biomarkers. By capturing these signatures in a cloud-based library, iLoF enhances the drug discovery process, facilitating the identification and development of potential treatments for Alzheimer's.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Vesynta's technology combines drug monitoring hardware with precision dosing software to provide a universal bedside platform for evidence-based clinical decision support.

University College London (UCL) is a prominent multidisciplinary university located in London, recognized for its academic excellence and innovative research. Established in 1826, UCL was groundbreaking in its commitment to inclusivity, being the first university in England to admit students regardless of race, class, or religion, and the first to grant women equal access to education. Today, UCL is home to a diverse community of distinguished professors and talented students dedicated to addressing real-world challenges through research and learning. In addition to its broad academic offerings, UCL provides consultancy services through UCL Consultants, further extending its impact beyond traditional education. UCL also encompasses specialized schools, including UCL Medical School and UCL School of Pharmacy, reinforcing its status as a leading institution in various fields of study.

Curenetics are working hard using technology to defeat cancer.

NIHR London IVD Co-operative collaborates with industry and innovators to evaluate and improve emerging diagnostic tests and devices.